These observations suggest that further studies by cytokine quantification and in vitro experiments are required to depict the precise role of CgB and related peptides in the regulation of LV function and reserve capacity for patients with stable coronary artery disease and CTO, especially after successful revascularization. This evidence concerns the gene CHGB and coronary artery disorder.